Our multidisciplinary team includes scientists and clinicians who are using the latest technology to identify the genes and proteins that cause cancer and are developing and offering novel and state-of-the-art therapeutic strategies for cancer diagnosis and treatment.

• Molecular Oncology and Cellular Oncology - unraveling the complex molecular pathways that disrupt the balance of cell growth and cell death in cancer.
• Oncogenomics and oncoproteomics - studying networks of genes and proteins that are disrupted in cancer using state-of-the-art and emerging genomic and proteomic technologies and databases.
• Oncogenetics - developing transgenic animal models for human cancer to better understand what causes cancer and develop and test new therapeutic strategies.
• Experimental Therapeutics - exploring novel strategies for controlling cancer growth and the spread of cancer.
• Tumor Cell Biology - understanding how a tumor grows and spreads to other sites.
• Genomic Integrity - discovering why and how the genetic material of developing tumor cells becomes damaged and unstable, focusing on the importance of DNA repair in cancer susceptibility.